Inclacumab (Anti-P-Selectin / CD62p)

Inclacumab (Anti-P-Selectin / CD62p) is a humanized monoclonal IgG4 antibody selectively targets P-selectin. It reduces cell adhesion showing potential for prevention of sickle cell disease (SCD). MW :150 KD.
Supplier Selleck Chemicals
Product # A2616
Sku # A2616-1mg*5
Pricing 1mg*5, $1690.00
Feedback